Leukaemia
A study to evaluate how well low-dose venetoclax with posaconazole works and how safe it is in patients with acute blood cancer who are not fit for standard chemotherapy.
Who can joinAdults
Age18+ years
Kind of studyObservational: no new treatment
What it testsWatches and records only
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
Tata Memorial HospitalMumbaiDirections ↗
Registry summary (technical)
A Phase 2 Feasibility Study of the Efficacy and Safety of Low-Dose Venetoclax and Posaconazole in Acute Myeloid Leukemia Patients Not Fit for 3+7 Induction Therapy. - NIL
Sponsor: CSR
CTRI/2026/04/109414 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 1 Jun 2026 · read by us 5 Nov 2026